← Back to Clinical Trials
Recruiting NCT06337500

NCT06337500 Validation of a Making Decision Hybrid (Ecologic and Virtual) Task

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT06337500
Status Recruiting
Phase
Sponsor Centre Hospitalier Universitaire de Besancon
Condition Healthy Volunteers
Study Type INTERVENTIONAL
Enrollment 180 participants
Start Date 2024-02-01
Primary Completion 2026-02-01

Eligibility & Interventions

Sex All sexes
Min Age 18 Years
Max Age 65 Years
Study Type INTERVENTIONAL
Interventions
Neurophysiological measure (EEG)Survey

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 180 participants in total. It began in 2024-02-01 with a primary completion date of 2026-02-01.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

The aim of this study is to validate a new hybrid (ecological + virtual) decision-making tool. The difference in behavior (risky choices) between the "hybrid" task and the "virtual" task will be evaluated.

Eligibility Criteria

Inclusion Criteria: * Men and women aged 18 to 65 inclusive * Subjects with no neurological or psychiatric disorders * Subjects with no addictive disorder except tobacco * Signed informed consent indicating that the subject has understood the purpose and procedures of the study and agrees to participate in the study and to abide by the requirements and restrictions inherent in the study * Affiliation with a French social security scheme or beneficiary of such a scheme. Exclusion Criteria: * Men and women under 18 or over 65 years of age * Subjects suffering from a neurological or psychiatric disorder * Subjects suffering from an addictive disorder, with the exception of tobacco * Legal incapacity or limited legal capacity * Subject unlikely to cooperate with the study and/or poor cooperation anticipated by the investigator * Subject without health insurance * Pregnant * Subject within the exclusion period of another study or on the "national volunteer list".

Contact & Investigator

Central Contact

Karine CHARRIERE, PhD

✉ kcharriere@chu-besancon.fr

📞 +333 81218999

Principal Investigator

Julie GIUSTINIANI, MD

PRINCIPAL INVESTIGATOR

CHU Besançon

Frequently Asked Questions

Who can join the NCT06337500 clinical trial?

This trial is open to participants of all sexes, aged 18 Years or older, up to 65 Years, studying Healthy Volunteers. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT06337500 currently recruiting?

Yes, NCT06337500 is actively recruiting participants. Contact the research team at kcharriere@chu-besancon.fr for enrollment information.

Where is the NCT06337500 trial being conducted?

This trial is being conducted at Besançon, France.

Who is sponsoring the NCT06337500 clinical trial?

NCT06337500 is sponsored by Centre Hospitalier Universitaire de Besancon. The principal investigator is Julie GIUSTINIANI, MD at CHU Besançon. The trial plans to enroll 180 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology